New Fourth Edition of Rheumatoid Arthritis: Diagnosis and Treatment
08-13-2014
PCI is pleased to announce the publication of the new fourth edition of Rheumatoid Arthritis: Diagnosis and Treatment by Drs. John J. Cush, Michael Weinblatt, and Arthur Kavanaugh.
Rheumatoid Arthritis: Diagnosis and Treatment reviews the importance of early treatment of RA, appropriate testing and imaging to be employed in diagnosis, and outcomes data on all available therapies for the treatment of early and established RA. Clinical evaluation is presented, including lab findings, joint scoring, diagnostic criteria, and radiographic outcomes.
The appropriate use of disease-modifying antirheumatic drugs (DMARDs) as monotherapy and in combination is presented. The use of TNF inhibitors in the early treatment of RA is reviewed in detail including pivotal clinical trials data.
Separate chapters are dedicated to interleukin-1 inhibitors, B-cell targeted therapies, T-cell pathway blockers, interleukin-6 inhibitors, and kinase inhibitors. The clinical efficacy, dosing, indications for use, mechanisms of action, side effects, and safety of all these biologic therapies are reviewed in detail. In addition, the appendix contains a how-to guide for setting up an early arthritis clinic.
There is a tremendous line-up of key opinion leader authors for this book, which include John J. Cush, MD, Professor of Medicine and Rheumatology at Baylor University and Director of Clinical Rheumatology at th Baylor Research Institute; Michael Weinblatt, MD, Professor of Medicine at Harvard Medical School; and Arthur Kavanaugh, MD, Professor of Clinical Medicine and Director of the Center for Innovative Therapy at the University of California, San Diego.
2014 • 432 pages • 4-color • $29.95 • ISBN: 978-1-932610-84-0